Please see full Important Safety Information below in the pinned post and
at www.miebo-ecp.com/#isi.
This product information is intended for US Healthcare audiences only.
MIEBO is a Bausch + Lomb brand and is not associated with any individual
users on LinkedIn.
You are encouraged to report negative side effects of prescription drugs to
the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information at MIEBO-ECP.com.
MIEBO is a trademark of Bausch + Lomb Incorporated or its affiliates.
© 2024 Bausch + Lomb | MBO.0532.USA.23
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.miebo-ecp.com
Miebo® (Perfluorohexyloctane Ophthalmic Solution) Questions
Miebo® (Perfluorohexyloctane Ophthalmic Solution)'s website is https://www.miebo-ecp.com
Miebo® (Perfluorohexyloctane Ophthalmic Solution)'s LinkedIn profile is https://www.linkedin.com/company/miebo
Miebo® (Perfluorohexyloctane Ophthalmic Solution)'s industry is
Pharmaceutical Manufacturing
Miebo® (Perfluorohexyloctane Ophthalmic Solution)'s top competitors are
Zeiss Medical Technology,
Alcon,
Rxsight, Inc.,
Tarsus Pharmaceuticals, Inc.,
Optos,
Coopervision,
Xiidra® (Lifitegrast Ophthalmic Solution) 5%,
Bausch + Lomb,
Lenz Therapeutics,
Topcon Healthcare.
Miebo® (Perfluorohexyloctane Ophthalmic Solution)'s categories are Pharmaceutical Manufacturing
